Skip to Main Content

Paper Details

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice.
Nat Med
37
2023
Author NameAffiliation
Donna ReichartHarvard Medical School
Donna ReichartUniversity Hospital
Gregory A NewbyMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT
Gregory A NewbyHoward Hughes Medical Institute
Gregory A NewbyHarvard University
David C PageHoward Hughes Medical Institute
David C PageMassachusetts Institute of Technology
David C PageWhitehead Institute
David R LiuMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT
David R LiuHoward Hughes Medical Institute
David R LiuHarvard University
Jonathan G SeidmanHarvard Medical School
Jonathan G SeidmanHarvard Medical School
Christine E SeidmanHarvard Medical School
Christine E SeidmanHoward Hughes Medical Institute
Christine E SeidmanBrigham and Women's Hospital
Christine E SeidmanHarvard Medical School
Christine E SeidmanHoward Hughes Medical Institute
Christine E SeidmanBrigham and Women's Hospital
  • 1 - 19

Datasets

Release 1.2